NASDAQ: PETS
Petmed Express Inc Stock

$4.25-0.22 (-4.92%)
Updated Feb 14, 2025
PETS Price
$4.25
Fair Value Price
N/A
Market Cap
$87.79M
52 Week Low
$2.90
52 Week High
$6.85
P/E
425x
P/B
0.91x
P/S
0.4x
PEG
2.24x
Dividend Yield
N/A
Revenue
$247.01M
Earnings
$357.00k
Gross Margin
27.7%
Operating Margin
0.57%
Profit Margin
0.1%
Debt to Equity
0.51
Operating Cash Flow
$5M
Beta
0.71
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PETS Overview

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine PETS's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Pharmaceutical Retailer

Industry Rating
F
PETS
Ranked
#3 of 5

Top Ranked Stocks in Industry

View Top Pharmaceutical Retailer Stocks

Be the first to know about important PETS news, forecast changes, insider trades & much more!

PETS News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PETS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PETS ($4.25) is trading above its intrinsic value of $0.69, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PETS is poor value based on its earnings relative to its share price (425x), compared to the US market average (37.91x)
P/E vs Market Valuation
PETS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PETS due diligence checks available for Premium users.

Valuation

PETS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
425x
Industry
2.07x
Market
37.91x
PETS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PETS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

PETS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.91x
Industry
0.86x
PETS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PETS price to earnings growth (PEG)

For valuing profitable companies with growth potential

PETS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

PETS's financial health

Profit margin

Revenue
$53.0M
Net Income
-$707.0k
Profit Margin
-1.3%
PETS's Earnings (EBIT) of $1.40M... subscribe to Premium to read more.
Interest Coverage Financials
PETS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$144.8M
Liabilities
$48.6M
Debt to equity
0.51
PETS's short-term assets ($68.38M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PETS's short-term assets ($68.38M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PETS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PETS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
-$777.0k
Financing
-$1.0k
PETS's operating cash flow ($4.83M)... subscribe to Premium to read more.
Debt Coverage Financials

PETS vs Pharmaceutical Retailer Stocks

TickerZen RatingMarket Cap1d %P/EP/B
PETSC$87.79M-4.92%425.00x0.91x
YI$65.77M+4.08%N/A-0.77x
SCNXF$27.00M-0.69%1.00x0.32x
CJJDD$8.85M-0.75%-0.52x0.41x
SSY$6.77M+13.18%6.87x0.48x

Petmed Express Stock FAQ

What is Petmed Express's quote symbol?

(NASDAQ: PETS) Petmed Express trades on the NASDAQ under the ticker symbol PETS. Petmed Express stock quotes can also be displayed as NASDAQ: PETS.

If you're new to stock investing, here's how to buy Petmed Express stock.

What is the 52 week high and low for Petmed Express (NASDAQ: PETS)?

(NASDAQ: PETS) Petmed Express's 52-week high was $6.85, and its 52-week low was $2.90. It is currently -37.96% from its 52-week high and 46.55% from its 52-week low.

How much is Petmed Express stock worth today?

(NASDAQ: PETS) Petmed Express currently has 20,656,457 outstanding shares. With Petmed Express stock trading at $4.25 per share, the total value of Petmed Express stock (market capitalization) is $87.79M.

Petmed Express stock was originally listed at a price of $8.38 in Apr 26, 1999. If you had invested in Petmed Express stock at $8.38, your return over the last 25 years would have been -49.25%, for an annualized return of -2.68% (not including any dividends or dividend reinvestments).

How much is Petmed Express's stock price per share?

(NASDAQ: PETS) Petmed Express stock price per share is $4.25 today (as of Feb 14, 2025).

What is Petmed Express's Market Cap?

(NASDAQ: PETS) Petmed Express's market cap is $87.79M, as of Feb 18, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Petmed Express's market cap is calculated by multiplying PETS's current stock price of $4.25 by PETS's total outstanding shares of 20,656,457.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.